Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$122.71 - $146.91 $61,355 - $73,455
-500 Reduced 41.67%
700 $99,000
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $122,532 - $163,103
1,200 New
1,200 $154,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.